These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 13410421)
21. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis. Gao P; Lu C; Zhang F; Sang P; Yang D; Li X; Kong H; Yin P; Tian J; Lu X; Lu A; Xu G Analyst; 2008 Sep; 133(9):1214-20. PubMed ID: 18709197 [TBL] [Abstract][Full Text] [Related]
22. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737 [TBL] [Abstract][Full Text] [Related]
23. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Sundström B; Stålnacke K; Hagfors L; Johansson G Scand J Rheumatol; 2006; 35(5):359-62. PubMed ID: 17062435 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis. Howe HS; Cheung PL; Kong KO; Badsha H; Thong BY; Leong KP; Koh ET; Lian TY; Cheng YK; Lam S; Teo D; Lau TC; Leung BP Rheumatology (Oxford); 2005 Jan; 44(1):51-4. PubMed ID: 15479754 [TBL] [Abstract][Full Text] [Related]
25. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Haibel H; Rudwaleit M; Listing J; Sieper J Ann Rheum Dis; 2005 Feb; 64(2):296-8. PubMed ID: 15208175 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement. Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681 [TBL] [Abstract][Full Text] [Related]
27. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. Pavy S; Brophy S; Calin A J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730 [TBL] [Abstract][Full Text] [Related]
28. Etanercept: new indication. For ankylosing spondylitis: another option. Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387 [TBL] [Abstract][Full Text] [Related]
29. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773 [TBL] [Abstract][Full Text] [Related]
30. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480 [TBL] [Abstract][Full Text] [Related]
31. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response. Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093 [TBL] [Abstract][Full Text] [Related]
32. Biological and clinical markers of disease activity in ankylosing spondylitis. Muñoz-Villanueva MC; Muñoz-Gomariz E; Escudero-Contreras A; Pèrez-Guijo V; Collantes-Estévez E J Rheumatol; 2003 Dec; 30(12):2729-32. PubMed ID: 14719229 [No Abstract] [Full Text] [Related]
33. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Stone M; Warren RW; Bruckel J; Cooper D; Cortinovis D; Inman RD Arthritis Rheum; 2005 Jun; 53(3):445-51. PubMed ID: 15934110 [TBL] [Abstract][Full Text] [Related]
34. [RAISE study observational and cross sectional study to evaluate the actual reality of the socio-economic impact of ankylosing spondylitis]. Miranda L; Negreiro F; Queiroz MJ; Silva C Acta Reumatol Port; 2008; 33(2):189-97. PubMed ID: 18604185 [TBL] [Abstract][Full Text] [Related]
35. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics. Stone MA; Inman RD; Wright JG; Maetzel A Arthritis Rheum; 2004 Jun; 51(3):316-20. PubMed ID: 15188313 [TBL] [Abstract][Full Text] [Related]
36. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis. Lubrano E; Sarzi Puttini P; Parsons WJ; D'Angelo S; Cimmino MA; Serino F; Pappone N Rheumatology (Oxford); 2005 May; 44(5):666-9. PubMed ID: 15757970 [TBL] [Abstract][Full Text] [Related]
37. Homozygous MM in ankylosing spondylitis. Brewerton DA; Pease CT; Godwin G; McCarthy DM Br J Rheumatol; 1987 Feb; 26(1):65. PubMed ID: 3814974 [No Abstract] [Full Text] [Related]
38. [Comparative statistical study of the results of laboratory investigations in patients with ankylosing spondylitis and in normal patients]. SUCHY K; TRUHLAR P; MALY V Acta Chir Orthop Traumatol Cech; 1957 Jan; 24(1):27-37. PubMed ID: 13410421 [No Abstract] [Full Text] [Related]
39. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449 [TBL] [Abstract][Full Text] [Related]
40. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population. Niederer R; Danesh-Meyer H N Z Med J; 2006 Mar; 119(1230):U1886. PubMed ID: 16532040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]